We recently published a list of 12 Best German Stocks to Buy According to Hedge Funds. In this article, we are going to take ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

Leerink Partners analyst Mani Foroohar maintained a Hold rating on CureVac (CVAC – Research Report) on March 27. The company’s shares closed ...

Pfizer (PFE) and other COVID shot makers such as Moderna (MRNA) will face investor scrutiny as FDA's top vaccine regulator Dr ...

Novo Nordisk may miss sales expectations; federal judge fines Johnson & Johnson $1.64 billion in marketing case; CureVac mRNA ...

CureVac N.V. secured funding with GSK amid financial struggles, while a key patent win boosts stock. Click for why my ...

Shares of CureVac climbed after the European Patent Office confirmed the validity of a patent that has been the subject of a lawsuit filed by BioNTech. The stock rose 7% to $2.99 on Friday. Shares ...

Stock futures edged lower on Friday as investors weighed tariff uncertainty alongside closely watched inflation data. The core PCE price index, the Federal Reserve's preferred inflation gauge, came in ...

CureVac's amended patent survives BioNTech's challenge as EPO upholds validity. A German court will decide on infringement in ...

Germany-headquartered CureVac (Nasdaq: CVAC) late Thursday announced that the European Patent Office (EPO) has confirmed the ...

Apple (NASDAQ: AAPL) stock fell 0.8% and Meta Platforms (NASDAQ: META) stock rose 0.1% after the Financial Times reported ...

In a legal battle between BioNTech and CureVac, the European Patent Office declared a patent owned by CureVac ...